The Rac1 exchange factor Dock5 is essential for bone resorption by osteoclasts

Area of Science:

• Cell Biology
• Bone Biology
• Pharmacology

Background:

• Osteoporosis is a major health concern in the elderly, characterized by excessive bone resorption by osteoclasts.
• Osteoclast function, particularly the formation of the sealing zone essential for bone resorption, relies on actin cytoskeleton regulation by Rho GTPases.
• Identifying key regulators of osteoclast activity is crucial for developing novel therapeutic strategies against osteoporosis.

Purpose of the Study:

• To investigate the role of the atypical Rac1 exchange factor Dock5 in osteoclast function and bone resorption.
• To determine if Dock5 is a potential therapeutic target for anti-osteoporotic treatments.

Main Methods:

• In vitro studies of osteoclast sealing zone formation and resorbing activity in the presence or absence of Dock5.
• Analysis of osteoclast adhesion, Rac1, and p130Cas activities.
• In vivo studies using Dock5 knockout mice (Dock5(-/-)) to assess trabecular bone mass and osteoclast numbers.
• Identification and testing of a novel small-molecule inhibitor of Dock5.

Main Results:

• Dock5 is required for the establishment of the sealing zone and osteoclast resorbing activity in vitro.
• Osteoclasts lacking Dock5 exhibit impaired adhesion due to perturbed Rac1 and p130Cas activities.
• A novel small-molecule inhibitor of Dock5 effectively reduced osteoclast resorbing activity.
• Dock5(-/-) mice display increased trabecular bone mass with normal osteoclast numbers, indicating Dock5's essential role in bone resorption but not osteoclast differentiation.

Conclusions:

• Dock5 is a critical regulator of osteoclast function, specifically mediating adhesion and bone resorption.
• Dock5 is essential for osteoclast resorbing activity in vitro and in vivo.
• Targeting Dock5 with small-molecule inhibitors presents a promising therapeutic approach for developing novel anti-osteoporotic treatments.